LNTH logo

LNTH Lantheus Holdings, Inc.

NASDAQ Global Market · Drug Manufacturers - Specialty & Generic · Healthcare

$102.10
+0.00 (+0.00%)

Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagno…

Market Cap: $6.68Bwww.lantheus.com

Price

No data yet.

Social Signal Score

51
5d
—
30d
45
4 mentions
—
60d
53
9 mentions
—
90d
54
12 mentions
—
marketaux: 2 · news: 9 · 4chan: 1

Analyst Ratings

19 analysts
Buyconsensus
Strong Buy 0Buy 10Hold 9Sell 0Strong Sell 0
Avg price target$104.38+2.2%
Low $102.5Median $102.5High $109
Current Consensus

Revenue

$389.91M+424.43%
$66.01M$179.60M$293.19M$406.79M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$5.57
$5.31–$5.68
11 analysts
FY2026
$5.56-0% YoY
$5.12–$5.90
3 analysts
FY2027
$6.77+22% YoY
$6.50–$7.23
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Mary Anne Heino
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,193
Beta
-0.06
Country
US
Piotroski score
8 / 9 (Strong)
Altman Z-score
5.65
www.lantheus.com